Latest ROE for Genelux: -209.73% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-209.73%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Genelux (GNLX) currently reports a ROE of -209.73%. That is below the sector sector average of 11.64%. Use the charts on this page to explore Genelux's ROE history and peer comparisons.
Genelux's ROE of -209.73% is lower than the its sector sector average of 11.64%. That is roughly 1902.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Genelux's current -209.73% should be judged against industry norms (sector average: 11.64%) and against GNLX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -209.73%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.64%. From there, open related valuation or income-statement pages for Genelux, and consider following GNLX for alerts when major investors trade the stock.